PLoS ONE 11 , e0165125 (2016)
The medication will need to be gradually increased in dosage over weeks or months, allowing for the patients body to become accustomed to the medication and to allow for any changes to the medication to be made in case they are not responding well to that specific type
Only 1 in 8 Americans have optimal metabolic measures and every 0.5% increase in A1c above 5.0% increases coronary heart disease risk by 29%
Some patients report that the daily injection becomes routine and less anxiety-provoking over time, whilst others find the frequency burdensome
Understanding your genetic and biomarker profile before starting GLP-1 allows your provider to anticipate GI tolerability, design a titration schedule that matches your adaptation capacity, and select a formulation (PlexusDx offers compounded semaglutide, tirzepatide, and micro-dose protocols) aligned with your risk profile
Your healthcare provider will closely monitor your progress, adjust dosages as needed, and address any potential side effects